We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+12.16%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$43.2B
AUM Growth
+$461M
(+1.1%)
Cap. Flow
-$3.13B
Cap. Flow
% of AUM
-7.24%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
2,717
New
237
Increased
842
Reduced
1,328
Closed
284
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$438M |
| 2 |
Humana
HUM
|
+$375M |
| 3 |
Nike
NKE
|
+$306M |
| 4 |
Gilead Sciences
GILD
|
+$301M |
| 5 |
Pfizer
PFE
|
+$292M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$368M |
| 2 |
Merck
MRK
|
+$325M |
| 3 |
Rivian
RIVN
|
+$279M |
| 4 |
Microsoft
MSFT
|
+$266M |
| 5 |
CVS Health
CVS
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.11% |
| 2 | Healthcare | 13.15% |
| 3 | Consumer Discretionary | 12.01% |
| 4 | Financials | 11.68% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
NetSol Technologies
NTWK
$51.3M
| $29.9K | ﹤0.01% |
10,800
| – | – |
|
|
CRDL
2377
Cardiol Therapeutics
CRDL
$138M
| $29.9K | ﹤0.01% |
16,500
-400
| -2% | -$539 |
|
|
CMMB
2378
Chemomab Therapeutics
CMMB
$10.5M
| $29.4K | ﹤0.01% |
9,450
+600
| +7% | +$1.54K |
|
|
CBD
2379
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $29.4K | ﹤0.01% |
46,700
-30,589
| -40% | -$22.5K |
|
2380
Entravision Communication
EVC
$1.01B
| $29.4K | ﹤0.01% |
17,900
-13,000
| -42% | -$42.9K |
|
2381
Traeger
COOK
$164M
| $29.1K | ﹤0.01% |
+230
| New | +$26.2K |
|
2382
Wheels Up
UP
$200M
| $28.8K | ﹤0.01% |
502
-123
| -20% | -$8.1K |
|
|
CMRX
2383
DELISTED
Chimerix, Inc.
CMRX
| $28.6K | ﹤0.01% |
27,000
+4,700
| +21% | +$4.89K |
|
2384
Spectral AI
MDAI
$49.6M
| $28.5K | ﹤0.01% |
+13,400
| New | +$30.3K |
|
2385
Perspective Therapeutics
CATX
$327M
| $27.5K | ﹤0.01% |
2,310
-930
| -29% | -$7.93K |
|
|
SOL
2386
DELISTED
Emeren Group
SOL
| $27.4K | ﹤0.01% |
14,200
-8,200
| -37% | -$16.7K |
|
|
OKUR
2387
OnKure Therapeutics
OKUR
$160M
| $26.9K | ﹤0.01% |
+1,620
| New | +$26.7K |
|
2388
Babcock & Wilcox
BW
$1.31B
| $26K | ﹤0.01% |
23,034
-112,000
| -83% | -$139K |
|
2389
Avalon Holdings
AWX
$10.1M
| $25.6K | ﹤0.01% |
11,500
| – | – |
|
|
HOOK
2390
DELISTED
HOOKIPA Pharma
HOOK
| $25.3K | ﹤0.01% |
+3,560
| New | +$25.3K |
|
|
TUYA
2391
Tuya Inc
TUYA
$1.02B
| $24.3K | ﹤0.01% |
13,900
| – | – |
|
|
LILM
2392
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
| $23.8K | ﹤0.01% |
24,800
-84,700
| -77% | -$78.7K |
|
|
ACHL
2393
DELISTED
Achilles Therapeutics
ACHL
| $22.4K | ﹤0.01% |
+17,900
| New | +$19.3K |
|
2394
Xeris Biopharma Holdings
XERS
$1.42B
| $22.3K | ﹤0.01% |
+10,097
| New | +$26.1K |
|
|
HLTH
2395
DELISTED
Cue Health Inc. Common Stock
HLTH
| $22.3K | ﹤0.01% |
118,100
-23,300
| -16% | -$5.29K |
|
2396
Ring Energy
REI
$287M
| $22.1K | ﹤0.01% |
11,300
-145,400
| -93% | -$216K |
|
|
CDTX
2397
DELISTED
Cidara Therapeutics
CDTX
| $22K | ﹤0.01% |
1,195
-825
| -41% | -$11.8K |
|
|
RENT
2398
Rent the Runway
RENT
$119M
| $20.9K | ﹤0.01% |
3,025
-70
| -2% | -$666 |
|
|
AIFA
2399
All In FutureTech Alliance Inc
AIFA
$11.4M
| $20.9K | ﹤0.01% |
3,442
-75
| -2% | -$472 |
|
2400
Noodles & Co
NDLS
$88.2M
| $20.8K | ﹤0.01% |
1,363
+38
| +3% | +$742 |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Advisers held 2,717 positions worth $43.2B, up 1.1% from $42.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Two Sigma Advisers withdrew a net $3.13B in Q1 2024, closing 284 positions and reducing 1,328 holdings. Its most notable exit was Rivian, an estimated $279M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Advisers opened a new position in Walmart Inc worth $461M.
- Two Sigma Advisers's largest Q1 2024 buy was Walmart Inc: 7,653,900 shares worth $461M.
- Two Sigma Advisers added most to Humana in Q1 2024, an estimated $375M increase.
- Two Sigma Advisers's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $368M.
- Two Sigma Advisers fully exited Rivian in Q1 2024, selling an estimated $279M.
- Two Sigma Advisers's ten largest holdings make up 17% of its $43.2B portfolio in Q1 2024.
- Two Sigma Advisers opened 237 new positions and closed 284 in Q1 2024.
- Two Sigma Advisers's portfolio value rose 1.1% quarter-over-quarter to $43.2B.
Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.